Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory processes and Alzheimer's disease.

Sally Walsh1, Paul S Aisen

  • 1Department of Neurology, Georgetown University Medical Center, Washington, DC 20057, USA. spw9@georgetown.edu

Expert Review of Neurotherapeutics
|April 28, 2005
PubMed
Summary

The inflammatory hypothesis of Alzheimer's disease suggests anti-inflammatory drugs may help, but clinical trials have not proven effective. Further research is needed, but current anti-inflammatory treatments are not recommended.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment.

JAMA·2026
Same author

Relationships between longitudinal retinal amyloid imaging and amyloid PET in the A4 Trial.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Contributions of the Alzheimer's Disease Neuroimaging Initiative to advancing AD research: a targeted review of recent publications.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Divergent patterns of cognitive decline in preclinical Alzheimer's disease: Implications for secondary prevention trials.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Clinical impact of the Alzheimer's Disease Neuroimaging Initiative: A review of studies using ADNI data (2023 to June 2025).

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

The prognostic value of blood-based p-tau217 levels on progression to clinical impairment.

medRxiv : the preprint server for health sciences·2026

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pathophysiology

Background:

  • The inflammatory hypothesis of Alzheimer's disease (AD) proposes that inflammation plays a key role in AD development.
  • Anti-inflammatory drugs have been investigated for potential therapeutic benefits in AD over the past two decades.

Purpose of the Study:

  • To review the evidence supporting the inflammatory hypothesis of Alzheimer's disease.
  • To assess the progress and outcomes of clinical trials investigating anti-inflammatory treatments for AD.

Main Methods:

  • Review of existing clinical, epidemiological, and basic research studies on inflammation in AD.
  • Analysis of data from clinical trials involving various anti-inflammatory agents in AD patients.

Main Results:

Related Experiment Videos

  • Initial small trials showed promise, but larger subsequent trials with diverse anti-inflammatory agents failed to demonstrate significant benefits.
  • Potential reasons for treatment failure include issues with drug selection, dosage, and treatment timing/duration.

Conclusions:

  • Current anti-inflammatory treatments are not recommended for Alzheimer's disease based on available evidence.
  • Additional research is warranted to fully understand the role of inflammation and potential therapeutic strategies.